CD2 and Castleman disease: Supporting this hypothesis, physiological interactions between FcγRIIIa/CD16 and the co-stimulatory receptor CD2 were shown to be necessary to induce direct NK cytotoxicity but not ADCC in a patient with EBV-driven Castleman’s disease homozygous for H in position 66 (rs10127939) [19].